Chidamide Maintenance Therapy Following Induction Therapy in Patients With Peripheral T-Cell Lymphoma Who Are Ineligible for Autologous Stem Cell Transplantation: Case Series From China

Chidamide Maintenance Therapy Following Induction Therapy in Patients With Peripheral T-Cell Lymphoma Who Are Ineligible for Autologous Stem Cell Transplantation: Case Series From China

ObjectiveTo assess the potential benefit of chidamide maintenance therapy after induction treatment in peripheral T-cell lymphoma (PTCL).Materials and MethodsThe clinical data of 48 transplantation-ineligible patients with different PTCL subtypes who received continuous chidamide treatment after fir...

Full description

Bibliographic Details
Main Authors: Wei Guo, Xingtong Wang, Jia Li, Xianying Yin, Yangzhi Zhao, Yang Tang, Anna Wang, Ou Bai
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-06-01
Series:Frontiers in Oncology
Subjects:
chidamide
PTCL
maintenance therapy
ASCT ineligible
induction therapy
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.875469/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2022.875469/full

Similar Items